Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn screening (NBS) programs have traditionally relied on ...

MedGenome unveils MetaSeq, a groundbreaking blood test capable of detecting over 1,400 pathogens in just five days, enhancing ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

Quest expects the new blood test will support response monitoring in clinical trials.

MedGenome expands its infectious disease testing portfolio with MetaSeq, a single test that detects over 1,400 pathogens: Our Bureau, Bengaluru Thursday, February 5, 2026, 14:15 H ...

Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn ...

The global HLA typing market is expected to expand at a compound annual growth rate (CAGR) of approximately 6% during the ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

UConn Health, JAX partner to offer methylome profiling, enabling precision treatment Dr. Qian Wu, UConn Health ...

Phantasy Star Online 2 New Genesis recently held an NGS Headline livestream to show off everything happening during February ...

The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value healthcare solutions for transplant ...